Yiming Lu

发表

S-1 plus oxaliplatin vs. S-1 as first-line treatment in patients with previously untreated advanced gastric cancer: a randomized phase II study

Jun Zhang, Yiming Lu, Zanchao Liu, 2014, Journal of chemotherapy.

Sintilimab plus oxaliplatin/capecitabine (CapeOx) as neoadjuvant therapy in patients with locally advanced, resectable gastric (G)/esophagogastric junction (GEJ) adenocarcinoma.

N. Xu, Zhongqi Li, Haiyong Wang, 2021 .

Adjuvant Second-Dose Chemotherapy before Surgery for Patients with Locally Advanced Rectal Malignancy Is Not Beneficial: A Systematic Review and Meta-Analysis

Min Chen, Liang-zhou Chen, Lin Xu, 2017, Gastroenterology research and practice.